HR 5581
115th Congress
House
Crime and Law Enforcement
Cancer
Congressional oversight
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Government studies and investigations
Health personnel
Licensing and registrations
Long-term, rehabilitative, and terminal care
Medical education
Prescription drugs
ADAPT Act of 2018
Introduced: April 23, 2018
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 22, 2018
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Apr 23, 2018
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 23, 2018
Introduced in House
Plain-English summary
Abuse Deterrent and Prescriber Training Act of 2018 or the ADAPT Act of 2018
This bill amends the Controlled Substances Act to prohibit the Drug Enforcement Administration from registering, or renewing the registration of, a practitioner who is licensed to prescribe opioids in schedule II, III, IV, or V unless the practitioner completes a training program that includes information on opioids.
The Government Accountability Office must report to Congress on the effects of the amendments made by this bill, including whether there has been a reduction in opioids prescribed and in opioid-related overdoses and death.
What's happening now
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Committees of jurisdiction
3
Cosponsors
1